Intraday BUY SELL Signals
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
BUFR vs EAPR
BUFR vs EAPR Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
BUFR vs. EAPR commentary
Dec 26, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUFR is a Buy and EAPR is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
BUFR has more net assets: 8.38B vs. EAPR (78.1M). EAPR has a higher annual dividend yield than BUFR: EAPR (14.812) vs BUFR (12.898). BUFR was incepted earlier than EAPR: BUFR (5 years) vs EAPR (5 years). EAPR (0.89) has a lower expense ratio than BUFR (0.95).
| BUFR | EAPR | BUFR / EAPR | |
| Gain YTD | 12.898 | 14.812 | 87% |
| Net Assets | 8.38B | 78.1M | 10,729% |
| Total Expense Ratio | 0.95 | 0.89 | 107% |
| Turnover | 1.00 | N/A | - |
| Yield | 0.00 | 0.00 | - |
| Fund Existence | 5 years | 5 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| BUFR | EAPR | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 65% |
| Stochastic ODDS (%) | 2 days ago 57% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 65% |
| Advances ODDS (%) | 2 days ago 73% | 2 days ago 69% |
| Declines ODDS (%) | 11 days ago 64% | N/A |
| BollingerBands ODDS (%) | 2 days ago 54% | 3 days ago 74% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 69% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IPOS | 17.17 | 0.13 | +0.79% |
| Renaissance International IPO ETF | |||
| EMQQ | 41.53 | N/A | N/A |
| EMQQ The Emerging Markets Internet ETF | |||
| GUSA | 59.60 | N/A | N/A |
| Goldman Sachs MarketBeta US 1000 Eq ETF | |||
| THNR | 25.95 | N/A | N/A |
| Amplify Weight Loss Drug & Treatment ETF | |||
| GLV | 5.94 | -0.01 | -0.08% |
| Clough Global Dividend and Income Fund | |||